Please login to the form below

Not currently logged in
Email:
Password:

Lynn Lewis joins Envigo

She becomes the CRO’s senior vice president of global sales

EnvigoEnvigo, a contract research organisation, has appointed Lynn Lewis to the position of senior vice president of global sales, a new role created to strengthen the company’s position in the marketplace with a focus on customer service.

For the past 15 years Lewis worked for Covance, most recently as its group vice president of business development, clinical development and commercialisation services.

Her career has also seen her work for Eli Lilly leading cross-functional development teams bringing new medicines to market.

Dr Adrian Hardy, president and chief executive officer of Envigo, said: “We are thrilled Lynn Lewis has joined our team to drive this important effort.

“Lynn’s broad experience leading billion dollar, successful global sales organisations serving the biopharmaceutical industry will be an invaluable asset to our commercial team.”

Lewis’ new role will see her lead sales teams in North America, Europe and Asia Pacific, providing a focus on growth initiatives and enhancing customer experience.

28th February 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world
...